Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Healthcare Stock Q2 Earnings Roster for Aug 5: HUM, CRL & More
01:41pm, Tuesday, 04'th Aug 2020
The healthcare sector is expected to have benefited from solid demand for medical products and services in Q2, given the rising incidence of coronavirus cases as well as an ageing U.S. populace.
New Publication in Nature Cancer Demonstrates Signatera's Ability to Evaluate Tumor Response to Immunotherapy
03:20pm, Monday, 03'rd Aug 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a manuscript in Nature Cancer1 that validates the ability of its Signatera™ pers
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Analysts Estimate Natera (NTRA) to Report a Decline in Earnings: What to Look Out for
04:33pm, Wednesday, 29'th Jul 2020
Natera (NTRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Natera Announces Second Quarter 2020 Earnings Conference Call
01:03pm, Wednesday, 29'th Jul 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2020, after the market close on Au
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
Natera Inc (NTRA): Are Hedge Funds Right About This Stock?
04:33pm, Tuesday, 14'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Natera Recognized as a 'Force for Change' by Leading Women Entrepreneurs (LWE)
01:03pm, Tuesday, 14'th Jul 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, has received the Force for Change Illuminator award from LWE, accepted by Sheetal Parmar, Natera's VP of Medical Affa
Morgan Stanley Cuts Stock Holdings in Natera Inc (NASDAQ:NTRA)
07:04am, Sunday, 12'th Jul 2020
Morgan Stanley reduced its holdings in Natera Inc (NASDAQ:NTRA) by 60.8% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
AbbVie Inc (NYSE: ABBV)
ADC...
Robert Alan Schueren Sells 6,362 Shares of Natera Inc (NASDAQ:NTRA) Stock
07:18am, Saturday, 27'th Jun 2020
Natera Inc (NASDAQ:NTRA) COO Robert Alan Schueren sold 6,362 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $45.47,
Natera: Why COVID-19 Will Bring Out Q2 Shorts Leaving 2021 A Buy
07:31am, Friday, 26'th Jun 2020
Natera Inc. has become a major player in the diagnostics market operating with proprietary molecular and bioinformatics technology. Revenues in 2019 were impres
Baird Financial Group Inc. Acquires New Position in Natera Inc (NASDAQ:NTRA)
07:19am, Wednesday, 24'th Jun 2020
Baird Financial Group Inc. bought a new position in shares of Natera Inc (NASDAQ:NTRA) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 7,
Natera Expands Lab Footprint With State-Of-The-Art Facility in Austin, Texas
01:03pm, Monday, 22'nd Jun 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, is pleased to announce the expansion of its laboratory facility in Austin, Texas, supporting greater test processing
